Research Programmes / Core Facilities

Mouse Mutant Core Facility
Marta Vilaseca
Annie Rodolosse
Nicholas Simon Berrow
Camille Stephan-otto Attolini
Nuno Vasconcelos

Research Programmes

  • More about Cell and Developmental Biology
  • More about Structural and Computational Biology
  • More about Molecular Medicine
  • More about Chemistry and Molecular Pharmacology
  • More about Oncology

Core Facilities & Services

Scientists at IRB Barcelona are supported by an extensive range of common core facilities that provide state-of-the-art technologies and scientific services. These facilities are a key asset for our research, allowing the Institute to obtain outstanding results. They are designed to incorporate the most novel technologies available and provide them to our researchers in the shortest time possible.

Interdisciplinary initiatives

IRB Barcelona's partnerships, with organisations in areas of mutual interest and expertise, aim to take advantage of the wealth of knowledge, resources and technologies so critical to advancing the field of biomedicine


8 Oct 2014

Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have managed to generate a fruit fly (Drosophila melanogaster) model that reproduces human colon cancer.

1 Oct 2014

The peptide —a small protein— beta-amyloid is strongly associated with Alzheimer’s disease; however, researchers are still looking for unequivocal proof that this peptide is the causal agent of the

22 Sep 2014

Today the European Research Council (ERC) has announced the “Proof of Concept” awards for 50 European projects.

19 Sep 2014

The Spanish Society of Neurology estimates that 600,000 people are affected by Alzheimer’s disease in this country.

Upcoming events

24 Oct

Speaker: Prof. Kristian Helin1-3,
1BRIC, University of Copenhagen, 2Centre for Epigenetics,
University of Copenhagen, 3DanStem, University of
Copenhagen, Denmark

29 Oct

Speaker: Dr. Maribel Geli,
The endocytic pathway and the actin cytoskeleton, IBMB- CSIC, Barcelona, Spain

17 Nov

Miquel Coll and Manuel Palacín, IRB Barcelona (Barcelona, Spain) and John E. Walker, Wellcome Trust (Cambridge, UK)
Barcelona, Spain. 17-19 November, 2014